Patent ID: 11945826
Assignee: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C | IPC C

Claim 11:
12. A crystalline form of (R)-3-(1,4-dimethyl-1H-benzo[d][1,2,3]triazol-5-yl)-3-(3-(((R)-2-ethyl-7-hydroxy-2,3-dihydropyrido[2,3-f][1,4]oxazepin-4(5H)-yl)methyl)-4-methylphenyl)propanoic acid mesylate salt hydrate, or a tautomer thereof, having an x-ray powder diffraction pattern comprising peaks at 19.84°, 17.25°, 21.06°, and 13.45°±0.2° 2θ as measured by x-ray powder diffraction using an x-ray wavelength of 1.5406 Å.